DocMorris AG

ROSE

CH0042615283

Drug Retailers

Market Closed - Swiss Exchange Other stock markets 09:01:05 05/06/2024 pm IST			5-day change	1st Jan Change
63 ^CHF	+1.20%		-5.19%	-14.58%

08:29am	DOCMORRIS : Jefferies gives a Buy rating	ZD
04/06	DOCMORRIS : Receives a Sell rating from UBS	ZD

DocMorris AG: DocMorris announces results of Tender Offer

May 14, 2024 at 10:32 am IST

DocMorris AG / Key word(s): Bond
DocMorris AG: DocMorris announces results of Tender Offer

14-May-2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.

Please find our press release under the following link:

https://ir-corporate.docmorris.com/en/investor-relations/convertible-bonds-2024

End of Inside Information

Language:	English
Company:	DocMorris AG
	Walzmühlestrasse 49
	8500 Frauenfeld
	Switzerland
ISIN:	CH0042615283
Listed:	SIX Swiss Exchange
EQS News ID:	1901981


End of Announcement	EQS News Service

1901981 14-May-2024 CET/CEST

Latest news about DocMorris AG

DOCMORRIS : Jefferies gives a Buy rating	11:59am	ZD
DOCMORRIS : Receives a Sell rating from UBS	04/06	ZD
Warburg: Several mid-caps attractive takeover targets - and Mercedes-Benz	27/05	DP
DOCMORRIS : Warburg Research reiterates its Buy rating	27/05	ZD
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	23/05
DOCMORRIS : Gets a Buy rating from Baader Bank	22/05	ZD
DOCMORRIS : Gets a Sell rating from UBS	21/05	ZD
DOCMORRIS : Sell rating from UBS	16/05	ZD
DocMorris Names Successor to Outgoing CFO	08/05	MT
DocMorris Launches Tender Offer for Convertible Bonds Due 2025	06/05	MT
DOCMORRIS : Deutsche Bank remains its Buy rating	23/04	ZD
DOCMORRIS : Hauck & Aufhauser gives a Buy rating	19/04	ZD
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	18/04
DOCMORRIS : Gets a Buy rating from Warburg Research	18/04	ZD
DOCMORRIS : Receives a Buy rating from Berenberg	18/04	ZD
DocMorris Completes CHF200 Million Convertible Bonds Offering	18/04	MT
DOCMORRIS : Gets a Buy rating from Baader Bank	17/04	ZD
DocMorris Issues CHF200 Million Convertible Bonds, Plans Tender Offer	17/04	MT
DOCMORRIS : Deutsche Bank gives a Buy rating	17/04	ZD
Swiss Stocks Flash Red as Geopolitical Risks Drag Sentiment	16/04	MT
DOCMORRIS : Warburg Research reiterates its Buy rating	16/04	ZD
DOCMORRIS : UBS reaffirms its Sell rating	16/04	ZD
DOCMORRIS : Gets a Buy rating from Jefferies	16/04	ZD
Swiss online drug delivery firm DocMorris reports slight miss in Q1 sales	16/04	RE
DocMorris' Q1 External Revenue Grows; FY24 Outlook Affirmed	16/04	MT

Chart DocMorris AG

Duration

Period

More charts

Company Profile

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Sector

Drug Retailers

Calendar

20/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for DocMorris AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

62.25 CHF

Average target price

99 CHF

Spread / Average Target

+59.04%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
DOCMORRIS AG	-14.58%	87Cr
WALGREENS BOOTS ALLIANCE, INC.	-38.66%	1.39TCr
JD HEALTH INTERNATIONAL INC.	-32.35%	1.07TCr
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-16.27%	712.2Cr
YIFENG PHARMACY CHAIN CO., LTD.	+10.79%	623.53Cr
MATSUKIYOCOCOKARA & CO.	-11.61%	596.12Cr
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+73.30%	471.61Cr
NAHDI MEDICAL COMPANY	-3.50%	456.15Cr
CLICKS GROUP LIMITED	-6.67%	387.49Cr
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-19.80%	317.28Cr

Other Drug Retailers

DocMorris AG

Equities

ROSE

CH0042615283

Drug Retailers

DocMorris AG: DocMorris announces results of Tender Offer

EPS Revisions